LECTURE: Refundable Cannabidiole in the international comparison
Holger Rönitz is one of the founders of THC Pharm GmbH, which originated from a patient initiative and supplies since 1998 critically ill patients with cannabinoids. Under GMP conditions for therapeutic use a variety of research and reference substances are produced there for over 15 years.Previously, he worked as a press officer for WWF and Greenpeace Int. and advised federal ministries and NGO's in change processes.
Lecture in German